Author/Authors :
Hakimzadeh Seyyed Mostafa نويسنده Health Management Research Centre , Barfar Eshagh نويسنده 1. Health Promotion Research Center, Zahedan University of Medical Sciences, Zahedan, Iran. , Bastani Peivand نويسنده Assistant Professor, Health Human Resource Research Center, School of Management and Medical Informatics, Shiraz University of Medical Sciences, Shiraz, Iran , Rezapour Aziz نويسنده PhD, Assistant Professor, Department of Health Economics, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran , Tahernejad Ali نويسنده Assistant Professor, Baqiat allah University of Medical Sciences, Tehran, Iran , Panahi Sirous نويسنده PhD, Assistant Professor, Department of Health Economics, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran
Abstract :
Background: Medicine is considered as strategic goods worldwide and, therefore, a huge
amount of health care budget is spent on it. To prepare universal access to appropriate health
services and achieve the health-related millennium development goals, rational use of drugs
is an essential goal in the health system. This study aimed to investigate the proportion of
drug prescription in three categories of injections, antibacterials agents and corticosteroids
in a 10 year period.
Methods: This is a descriptive study using data from an Iranian national insurance
organization and National Center of Drug Use. The data about prescribed drugs during 2003
to 2013 were collected and analyzed by Excel Microsoft software, version 2010.
Result: Results indicated that injections were decreased from 49.25% in 2003 to 46% in 2013;
also, antimicrobials had a decrease from 64.25% in 2003 to 42.2% in 2013. Totally, it was
reduced about 16% in the period of 10 years. Corticosteroids increased 10 % from 13% to
23% in 2013.
Conclusion: According the present findings that indicate irrational and increasing use of
corticosteroids and antimicrobials, it seems necessary for Iranian policy makers to pay specific
attention to customizing clinical and pharmaceutical guidelines along with improvement
of medical education system and rational prescription, holding scientific committees of
prescription supervision, arranging continuous and effective education of health personnel,
and improving public culture and community education.
